ICMR will conduct a study to find the efficacy of the BCG vaccine against COVID-19. ICMR said that till any definitive result is reached it will not recommend the vaccine even for healthcare workers.
(BCG) is a vaccine primarily used against tuberculosis. Researchers in Boston, Australia and the Netherlands have also been conducting trials to investigate the potential of BCG against the novel coronavirus.
Facebook: The ICMR will now study the effectiveness of the TB vaccine against COVID-19, research on the same vaccine is also happening in the Netherlands, Australia and in Boston. To find a possible treatment for the new coronavirus, the governments of Punjab and Gujarat today also gave a nod to plasma transfusion therapy.
Watch daily coronavirus updates on The Wire to learn more.
Read | [ Ссылка ]
Like our work? Click here to support The Wire: [ Ссылка ]
The founding premise of The Wire is this: if good journalism is to survive and thrive, it can only do so by being both editorially and financially independent. This means relying principally on contributions from readers and concerned citizens who have no interest other than to sustain a space for quality journalism. As a publication, The Wire will be firmly committed to the public interest and democratic values.
We publish in four different languages!
For English, visit www.thewire.in
for Hindi: [ Ссылка ]
for Urdu: [ Ссылка ]
for Marathi: [ Ссылка ]
If you are a young writer or a creator, you can submit articles, essays, photos, poetry – anything that’s straight out of your imagination – to LiveWire, The Wire’s portal for the young, by the young. [ Ссылка ]
You can also follow The Wire’s social media platforms and engage with us.
Facebook
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
Twitter
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
Instagram
[ Ссылка ]
[ Ссылка ]
Don’t forget to hit the subscribe button to never miss a video from The Wire!
